Drug Shortage Report for TEVA-TOBRAMYCIN
| Report ID | 227495 |
| Drug Identification Number | 02389622 |
| Brand name | TEVA-TOBRAMYCIN |
| Common or Proper name | TOBRAMYCIN 300mg/5ml |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 60MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 56 |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-05-08 |
| Estimated end date | 2025-12-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v38 | 2025-11-27 | French | Compare |
| v37 | 2025-11-27 | English | Compare |
| v36 | 2025-10-02 | French | Compare |
| v35 | 2025-10-02 | English | Compare |
| v34 | 2025-09-11 | French | Compare |
| v33 | 2025-09-11 | English | Compare |
| v32 | 2025-08-21 | French | Compare |
| v31 | 2025-08-21 | English | Compare |
| v30 | 2025-08-08 | French | Compare |
| v29 | 2025-08-08 | English | Compare |
| v28 | 2025-06-13 | French | Compare |
| v27 | 2025-06-13 | English | Compare |
| v26 | 2025-04-24 | French | Compare |
| v25 | 2025-04-24 | English | Compare |
| v24 | 2025-04-10 | French | Compare |
| v23 | 2025-04-10 | English | Compare |
| v22 | 2025-02-28 | French | Compare |
| v21 | 2025-02-28 | English | Compare |
| v20 | 2025-02-20 | French | Compare |
| v19 | 2025-02-20 | English | Compare |